Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term **"activated myeloid lineage leukocyte"** refers to any white blood cell derived from the myeloid branch of hematopoiesis that is in an activated state. The **myeloid lineage** includes granulocytes (neutrophils, eosinophils, basophils), monocytes (which can differentiate into macrophages), dendritic cells, erythrocytes, and megakaryocytes/platelets. Among these, only granulocytes and mononuclear phagocytic cells are considered leukocytes involved in immune responses. Upon activation—typically by infection or tissue injury—these cells perform functions such as phagocytosis of pathogens/debris, secretion of inflammatory cytokines and chemokines, antigen presentation to T cells (especially by dendritic cells and macrophages), and orchestration of both innate and adaptive immunity. Dysregulation or abnormal activation is implicated in diseases like leukemia/cancer,[1] chronic inflammation,[3] autoimmune disorders,[1] infections,[2][4] and tissue damage. However, **"activated myeloid lineage leukocyte" is not a canonical molecular target** but rather a descriptive term encompassing multiple distinct immune cell types at various stages of activation.[5][6] It does not refer to a unique protein/receptor/enzyme/transporter but rather an entire class/family of functionally related immune cells.[5] Because it lacks specificity—it could mean any activated neutrophil/monocyte/macrophage/dendritic cell—the entry should be flagged as incorrect for structured drug-target databases seeking molecular targets. > "Myeloid lineage plays a crucial role in the immune system... including its definition [and] different cell types... Granulocytes... monocytes... dendritic cells..."[1] > "Granulocytes [and] monocytes serve as progenitors for macrophages and dendritic cells... Each type participates in the immune response..."[2] In summary: **This entry describes an entire functional group rather than a discrete therapeutic target molecule/receptor. For structured data purposes it should be marked incorrect unless further specified down to individual molecules such as 'CD14', 'CSF1R', etc., which are actual drug targets within this family.**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activated myeloid lineage leukocyte.